-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Boston Scientific, Raises Price Target to $130

Benzinga·12/17/2025 13:14:01
Listen to the news
RBC Capital analyst Shagun Singh maintains Boston Scientific (NYSE:BSX) with a Outperform and raises the price target from $125 to $130.